MX2011012735A - Composicion estabilizada que comprende por lo menos un compuesto adrenergico. - Google Patents

Composicion estabilizada que comprende por lo menos un compuesto adrenergico.

Info

Publication number
MX2011012735A
MX2011012735A MX2011012735A MX2011012735A MX2011012735A MX 2011012735 A MX2011012735 A MX 2011012735A MX 2011012735 A MX2011012735 A MX 2011012735A MX 2011012735 A MX2011012735 A MX 2011012735A MX 2011012735 A MX2011012735 A MX 2011012735A
Authority
MX
Mexico
Prior art keywords
adrenergic compound
stabilised composition
compound
stabilised
composition
Prior art date
Application number
MX2011012735A
Other languages
English (en)
Inventor
Alan J Baillie
Kenneth Macdonald
Pamela Porteous
Simon Hendry
Original Assignee
Alk Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Ag filed Critical Alk Ag
Publication of MX2011012735A publication Critical patent/MX2011012735A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Una composición estabilizada que comprende por lo menos un compuesto adrenérgico y por lo menos un antioxidante seleccionado del grupo que consiste de un bisulfito, un metabisulfito y un compuesto de sulfito.
MX2011012735A 2009-06-04 2010-06-03 Composicion estabilizada que comprende por lo menos un compuesto adrenergico. MX2011012735A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18406609P 2009-06-04 2009-06-04
DKPA200900705 2009-06-04
PCT/EP2010/057772 WO2010139752A2 (en) 2009-06-04 2010-06-03 Stabilised composition comprising at least one adrenergic compound

Publications (1)

Publication Number Publication Date
MX2011012735A true MX2011012735A (es) 2012-02-28

Family

ID=41364279

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2011012732A MX2011012732A (es) 2009-06-04 2010-06-03 Composicion estabilizada que comprende por lo menos un compuesto adrenergico.
MX2011012735A MX2011012735A (es) 2009-06-04 2010-06-03 Composicion estabilizada que comprende por lo menos un compuesto adrenergico.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2011012732A MX2011012732A (es) 2009-06-04 2010-06-03 Composicion estabilizada que comprende por lo menos un compuesto adrenergico.

Country Status (15)

Country Link
US (1) US9155694B2 (es)
EP (2) EP2437782B1 (es)
JP (2) JP2012528830A (es)
KR (2) KR20120044309A (es)
CN (3) CN102497882A (es)
AU (2) AU2010255747B2 (es)
BR (2) BRPI1011074A2 (es)
CA (2) CA2764050C (es)
DK (2) DK2437782T3 (es)
ES (2) ES2432241T3 (es)
MX (2) MX2011012732A (es)
PT (2) PT2437782E (es)
RU (2) RU2527337C9 (es)
SI (2) SI2437781T1 (es)
WO (2) WO2010139752A2 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8628805B2 (en) * 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
CN102525893B (zh) * 2012-01-04 2013-11-20 上海禾丰制药有限公司 盐酸去氧肾上腺素注射液及其制剂工艺
CN102525894A (zh) * 2012-01-04 2012-07-04 上海禾丰制药有限公司 盐酸异丙肾上腺素注射液及其制剂工艺
AU2013328393A1 (en) * 2012-10-08 2015-04-09 Wockhardt Limited Stable injectable pharmaceutical composition of epinephrine or salts thereof
TWI641381B (zh) * 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
US20150231334A1 (en) * 2013-12-18 2015-08-20 Windgap Medical, Inc. Drug mixing and delivery system and method
BR112016007328A2 (pt) * 2013-10-03 2017-08-01 Imprimis Pharmaceuticals Inc composições oftálmicas baseadas em epinefrina para administração intraocular e métodos para fabricar as mesmas
CN103520096B (zh) * 2013-10-25 2015-02-25 成都晶博生物科技有限责任公司 一种硫酸特布他林注射液的生产工艺
SG11201604710XA (en) 2014-01-09 2016-07-28 Sanofi Sa Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
UY35988A (es) * 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
ES2770731T3 (es) * 2014-08-28 2020-07-02 Sun Pharmaceutical Ind Ltd Forma de dosificación parenteral de norepinefrina
WO2016100949A2 (en) * 2014-12-18 2016-06-23 Windgap Medical, Inc. Method and compositions for dissolving or solubilizing therapeutic agents
US9119876B1 (en) 2015-03-13 2015-09-01 Par Pharmaceutical, Inc. Epinephrine formulations
US20170189352A1 (en) 2015-03-13 2017-07-06 Par Pharmaceutical, Inc. Epinephrine formulations
US10039710B2 (en) * 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
US11517525B2 (en) * 2015-09-18 2022-12-06 Hikma Pharmaceuticals Usa Inc. Epinephrine spray formulations
AU2017315757A1 (en) * 2016-08-25 2019-03-07 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
RU2635759C1 (ru) * 2016-09-13 2017-11-15 Интеллег Сосьете Анониме Фармацевтическая композиция для парентерального введения и способ ее получения
US10835503B2 (en) * 2017-01-13 2020-11-17 Teva Pharmaceuticals Usa, Inc. Pre-filled syringe
CA3051467C (en) 2017-01-30 2022-11-29 Nevakar, Inc Norepinephrine compositions and methods therefor
ES2960528T3 (es) * 2017-04-17 2024-03-05 Hikma Pharmaceuticals Usa Inc Formulaciones de epinefrina en aerosol
WO2019067505A1 (en) 2017-09-26 2019-04-04 Ys Pharmtech STABILIZATION OF EPINEPHRINE FORMULATIONS
WO2019072723A1 (en) * 2017-10-10 2019-04-18 Merck Patent Gmbh STABILIZED INJECTABLE PHARMACEUTICAL COMPOSITIONS OF L-EPINEPHRINE
WO2019182745A1 (en) 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations
CA3093725C (en) 2018-03-23 2021-08-24 Nevakar Inc. Epinephrine compositions and containers
US10952963B2 (en) 2018-04-11 2021-03-23 QuVa Pharma, Inc. Ready to use liquid RECK formulation
US10952962B1 (en) 2018-04-11 2021-03-23 QuVa Pharma, Inc. Ready to use liquid formulation
US10478406B2 (en) 2019-03-18 2019-11-19 HARC Therapeutics AG High-pH solid-state epinephrine formulation
CN116474219A (zh) * 2019-06-28 2023-07-25 四川普锐特药业有限公司 保持给药均一度的药物流体分配器及右美托咪定鼻喷器
WO2021024237A1 (en) 2019-08-08 2021-02-11 Sun Pharmaceutical Industries Limited Infusion dosage form of norepinephrine
USD1004518S1 (en) 2019-09-09 2023-11-14 Brunswick Corporation Railing for a marine vessel
USD984953S1 (en) 2021-05-03 2023-05-02 Brunswick Corporation Safely railing having buoy holder
AU2021203856B2 (en) * 2021-06-10 2023-03-09 Animal Ethics Pty Ltd Topical anaesthetic composition having improved vasoconstrictor stability
WO2024047474A1 (en) * 2022-08-27 2024-03-07 Biophore India Pharmaceuticals Pvt. Ltd Trientine liquid dosage forms

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB425678A (en) 1933-06-15 1935-03-15 Novocol Chemical Mfg Co Inc Improvements relating to anesthetics for hypodermic injection
US2047144A (en) 1934-03-26 1936-07-07 Lilly Co Eli Stabilized epinephrine-type compound, and process of stabilizing it
US2382546A (en) * 1941-11-03 1945-08-14 Curtis David Anesthetic solutions
NL277824A (es) * 1961-04-28
US3419035A (en) * 1965-05-25 1968-12-31 Badger Meter Mfg Co Air elimination device for liquid transport system
CA981182A (en) 1972-01-07 1976-01-06 Walter A. Borisenok Stabilization of 1-epinephrine in local anesthetic solutions with a combination of three antioxidants
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
DD150694A1 (de) 1980-04-16 1981-09-16 Gisela Raether Verfahren zur stabilisierung von pharmazeutischen praeparaten mit oxidationsempfindlichen bestandteilen
US4734438A (en) 1983-04-26 1988-03-29 Macri Frank J Norepinephrine potentiated compositions and method of use
AU5680994A (en) 1992-12-10 1994-07-04 Abbott Laboratories Stabilized catecholamine solutions
JP3535537B2 (ja) * 1993-04-15 2004-06-07 日本製薬株式会社 静脈注射剤
US6077545A (en) 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
WO1998020869A2 (en) 1996-11-14 1998-05-22 Alza Corporation Formulation for electrically assisted delivery of lidocaine and epinephrine
EP0948965B1 (en) * 1997-07-11 2004-06-02 Toray Industries, Inc. Stable medicinal compositions containing 4,5-epoxymorphinane derivatives
JP4393641B2 (ja) 1998-11-26 2010-01-06 久光製薬株式会社 イオントフォレーシス用粘着ゲル組成物及びその装置
JP2004509920A (ja) 2000-09-29 2004-04-02 ボード　オブ　トラスティーズ　オペレーティング　ミシガン　ステート　ユニヴァーシティ カテコールアミン医薬組成物および方法
US8496930B2 (en) * 2003-10-01 2013-07-30 Kyowa Hakko Kirin Co., Ltd Method of stabilizing antibody and stabilized solution-type antibody preparation
UA71839C2 (uk) * 2003-12-30 2007-06-25 Товариство З Обмеженою Відповідальністю "Фарм-Стом" Фармацевтична композиція на основі артикаїну та епінефрину
US20050228336A1 (en) 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
US20060129122A1 (en) 2004-12-06 2006-06-15 Wyrick Ronald E Method and apparatus for delivering epinephrine
DK2010220T3 (da) * 2006-04-03 2022-05-23 Ceva Animal Health Pty Ltd Stabiliserede pentosanpolysulfat-(pps)-formuleringer
US20070249727A1 (en) * 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US20080269347A1 (en) * 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
US8628805B2 (en) 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound

Also Published As

Publication number Publication date
AU2010255747A1 (en) 2012-02-02
RU2011153410A (ru) 2013-07-20
DK2437782T3 (da) 2013-10-28
EP2437782A2 (en) 2012-04-11
DK2437781T3 (da) 2013-10-21
KR20120044309A (ko) 2012-05-07
KR20120028344A (ko) 2012-03-22
AU2010255747B2 (en) 2014-03-13
CA2764051A1 (en) 2010-12-09
ES2432164T3 (es) 2013-12-02
EP2437781A2 (en) 2012-04-11
PT2437782E (pt) 2013-10-30
EP2437781B1 (en) 2013-07-24
JP2012528830A (ja) 2012-11-15
BRPI1011074A2 (pt) 2016-04-12
CA2764050C (en) 2017-02-28
EP2437782B1 (en) 2013-07-24
PT2437781E (pt) 2013-10-30
WO2010139751A3 (en) 2011-04-07
CA2764050A1 (en) 2010-12-09
ES2432241T3 (es) 2013-12-02
AU2010255748B2 (en) 2014-03-13
WO2010139751A2 (en) 2010-12-09
CN102802668A (zh) 2012-11-28
US20120129944A1 (en) 2012-05-24
CN106109397A (zh) 2016-11-16
RU2011153403A (ru) 2013-07-20
BRPI1013019A2 (pt) 2016-03-29
WO2010139752A3 (en) 2011-04-07
SI2437782T1 (sl) 2013-12-31
RU2527337C9 (ru) 2014-12-27
SI2437781T1 (sl) 2013-12-31
JP2012528831A (ja) 2012-11-15
RU2527337C2 (ru) 2014-08-27
AU2010255748A1 (en) 2011-12-08
RU2527680C2 (ru) 2014-09-10
WO2010139752A2 (en) 2010-12-09
US9155694B2 (en) 2015-10-13
MX2011012732A (es) 2012-02-28
JP6087145B2 (ja) 2017-03-01
CN102497882A (zh) 2012-06-13

Similar Documents

Publication Publication Date Title
MX2011012732A (es) Composicion estabilizada que comprende por lo menos un compuesto adrenergico.
PH12017502300A1 (en) Pesticidal compositions and processes related thereto
PH12017501298A1 (en) Pesticidal compositions and processes related thereto
UA107791C2 (en) Pesticidal compositions
EP2325175A4 (en) 2,4-DIAMINOPYRIMIDINVERBINDUNG
EA200801959A1 (ru) Высокоразветвленный полипропилен
TR201907828T4 (tr) Geni̇ş spektrumlu bi̇r anti̇-mi̇krobi̇yel ajan
TWI349694B (en) A novel phosphor for white light-emitting diodes and fabrication of the same
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
ECSP10010491A (es) Composiciones fungicidas con 3'-bromo-2,3,4,6'-tetrametoxi-2',6-dimetilbenzofenona
GB201012090D0 (en) Cellulosic material
CL2008002704A1 (es) Composicion herbicida que comprende un compuesto derivado de 1,4-dihidro-2h-piridazin-3-ona.
SG163478A1 (en) Polymer stabilizer
UA37264U (en) Coordination compound of europium (iii) thenoyltrifluoroacetylacetonate with azeloylbis(3,5-dimethylpyrazol)
AU318769S (en) Kayak
UA43771U (ru) 5-r-4-r1-1,2,4-триазол-3-тионы, которые имеют антиоксидантную активность
UA27272U (en) Use of yakton as cardioprotector
UA29550U (en) Compound 1-(1',1'-difluoro-2'-bromo-2'-chloroethyl)-5-bromouracil with potential physiological properties
AU311604S (en) Sink
UA36194U (en) Use of quercetin as hepatoprotector
GR1005892B (el) Νεο θερμοκηπιο.
UA78894U (en) Nanostructure
PL382156A1 (pl) Sposób epoksydacji 1,4-bis (alliloksy) butanu
UA34276U (ru) 7-β-ГИДРОКСИЭТИЛ-3-МЕТИЛ-8-N-ПИРРОЛИДИНОКСАНТИН, КОТОРЫЙ ПРОЯВЛЯЕТ ДИУРЕТИЧЕСКОЕ ДЕЙСТВИЕ
UA35938U (en) 1-phenyl-o-tolylamino-1,5-dihydropyrrol-2-one having antioxidant activity

Legal Events

Date Code Title Description
FG Grant or registration